Education and Training
- Ph.D., University of North Carolina at Chapel Hill, 2011
- B.S., University of Virginia, 2003
Harowicz, MR, Robinson, TJ, Dinan, MA, Saha, A, Marks, JR, Marcom, PK, and Mazurowski, MA. "Algorithms for prediction of the Oncotype DX recurrence score using clinicopathologic data: a review and comparison using an independent dataset." Breast cancer research and treatment 162, no. 1 (February 2017): 1-10. (Review)
Kim, E, Dinan, M, Islam, KM, Fernandes, A, Schwartzberg, L, Croft, E, Brahmer, J, Mansfield, A, Hyslop, T, Burke, L, and Crawford, J. "PS01.61: Registry for the EVolution Of LUng Cancer Therapy Implementation and Outcomes Now (REVOLUTION): Registry Study in Progress: Topic: Medical Oncology." Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 11, no. 11S (November 2016): S308-S309.
Robinson, TJ, Thomas, S, Dinan, MA, Roman, S, Sosa, JA, and Hyslop, T. "How Many Lymph Nodes Are Enough? Assessing the Adequacy of Lymph Node Yield for Papillary Thyroid Cancer." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 34, no. 28 (October 2016): 3434-3439.
Ruel, E, Thomas, S, Dinan, MA, Perkins, JM, Roman, SA, and Sosa, JA. "Knowledge of pathologically versus clinically negative lymph nodes is associated with reduced use of radioactive iodine post-thyroidectomy for low-risk papillary thyroid cancer." Endocrine 52, no. 3 (June 2016): 579-586.
Roberts, MC, Bryson, A, Weinberger, M, Dusetzina, SB, Dinan, MA, Reeder-Hayes, KE, and Wheeler, SB. "Patient-Centered Communication for Discussing Oncotype DX Testing." Cancer investigation 34, no. 5 (May 2016): 205-212.
Cohen, SM, Dinan, MA, Kim, J, and Roy, N. "Otolaryngology utilization of speech-language pathology services for voice disorders." The Laryngoscope 126, no. 4 (April 2016): 906-912.
Dinan, MA, Li, Y, Zhang, Y, Stewart, SB, Curtis, LH, George, DJ, and Reed, SD. "Resource Use in the Last Year of Life Among Patients Who Died With Versus of Prostate Cancer." Clinical genitourinary cancer 14, no. 1 (February 2016): 28-37.e2.
Roberts, MC, Weinberger, M, Dusetzina, SB, Dinan, MA, Reeder-Hayes, KE, Carey, LA, Troester, MA, and Wheeler, SB. "Racial Variation in the Uptake of Oncotype DX Testing for Early-Stage Breast Cancer." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 34, no. 2 (January 2016): 130-138.
Roberts, MC, Bryson, A, Weinberger, M, Dusetzina, SB, Dinan, MA, Reeder-Hayes, K, and Wheeler, SB. "ONCOLOGISTS' BARRIERS AND FACILITATORS FOR ONCOTYPE DX USE: QUALITATIVE STUDY." International journal of technology assessment in health care 32, no. 5 (January 2016): 355-361.
Dinan, MA, Mi, X, Reed, SD, Lyman, GH, and Curtis, LH. "Association Between Use of the 21-Gene Recurrence Score Assay and Receipt of Chemotherapy Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005-2009." JAMA oncology 1, no. 8 (November 2015): 1098-1109.